Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Artificial Intelligence (AI) in Medical Diagnostics Market, by Application
1.4.2 North America Artificial Intelligence (AI) in Medical Diagnostics Market, by End User
1.4.3 North America Artificial Intelligence (AI) in Medical Diagnostics Market, by Component
1.4.4 North America Artificial Intelligence (AI) in Medical Diagnostics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Market Share Analysis, 2021
3.4 Top Winning Strategies
3.4.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.4.2 Key Strategic Move: (Product Launches and Product Expansions: 2018, Nov – 2022, Oct) Leading Players
Chapter 4. North America Artificial Intelligence (AI) in Medical Diagnostics Market by Application
4.1 North America In Vivo Diagnostics Market by Country
4.2 North America Artificial Intelligence (AI) in Medical Diagnostics Market by In Vivo Diagnostics Specialty Type
4.2.1 North America Radiology Market by Country
4.2.2 North America Cardiology Market by Country
4.2.3 North America Neurology Market by Country
4.2.4 North America Obstetrics/gynecology Market by Country
4.2.5 North America Ophthalmology Market by Country
4.2.6 North America Others Market by Country
4.3 North America Artificial Intelligence (AI) in Medical Diagnostics Market by In Vivo Diagnostics Modality Type
4.3.1 North America Computed Tomography Market by Country
4.3.2 North America X-Ray & Ultrasound Market by Country
4.3.3 North America Magnetic Resonance Imaging Market by Country
4.3.4 North America Others Market by Country
4.4 North America In Vitro Diagnostics Market by Country
Chapter 5. North America Artificial Intelligence (AI) in Medical Diagnostics Market by End User
5.1 North America Hospitals Market by Country
5.2 North America Diagnostics Imaging Centers Market by Country
5.3 North America Diagnostics Laboratories Market by Country
5.4 North America Others Market by Country
Chapter 6. North America Artificial Intelligence (AI) in Medical Diagnostics Market by Component
6.1 North America Services Market by Country
6.2 North America Software Market by Country
Chapter 7. North America Artificial Intelligence (AI) in Medical Diagnostics Market by Country
7.1 US Artificial Intelligence (AI) in Medical Diagnostics Market
7.1.1 US Artificial Intelligence (AI) in Medical Diagnostics Market by Application
7.1.1.1 US Artificial Intelligence (AI) in Medical Diagnostics Market by In Vivo Diagnostics Specialty Type
7.1.1.2 US Artificial Intelligence (AI) in Medical Diagnostics Market by In Vivo Diagnostics Modality Type
7.1.2 US Artificial Intelligence (AI) in Medical Diagnostics Market by End User
7.1.3 US Artificial Intelligence (AI) in Medical Diagnostics Market by Component
7.2 Canada Artificial Intelligence (AI) in Medical Diagnostics Market
7.2.1 Canada Artificial Intelligence (AI) in Medical Diagnostics Market by Application
7.2.1.1 Canada Artificial Intelligence (AI) in Medical Diagnostics Market by In Vivo Diagnostics Specialty Type
7.2.1.2 Canada Artificial Intelligence (AI) in Medical Diagnostics Market by In Vivo Diagnostics Modality Type
7.2.2 Canada Artificial Intelligence (AI) in Medical Diagnostics Market by End User
7.2.3 Canada Artificial Intelligence (AI) in Medical Diagnostics Market by Component
7.3 Mexico Artificial Intelligence (AI) in Medical Diagnostics Market
7.3.1 Mexico Artificial Intelligence (AI) in Medical Diagnostics Market by Application
7.3.1.1 Mexico Artificial Intelligence (AI) in Medical Diagnostics Market by In Vivo Diagnostics Specialty Type
7.3.1.2 Mexico Artificial Intelligence (AI) in Medical Diagnostics Market by In Vivo Diagnostics Modality Type
7.3.2 Mexico Artificial Intelligence (AI) in Medical Diagnostics Market by End User
7.3.3 Mexico Artificial Intelligence (AI) in Medical Diagnostics Market by Component
7.4 Rest of North America Artificial Intelligence (AI) in Medical Diagnostics Market
7.4.1 Rest of North America Artificial Intelligence (AI) in Medical Diagnostics Market by Application
7.4.1.1 Rest of North America Artificial Intelligence (AI) in Medical Diagnostics Market by In Vivo Diagnostics Specialty Type
7.4.1.2 Rest of North America Artificial Intelligence (AI) in Medical Diagnostics Market by In Vivo Diagnostics Modality Type
7.4.2 Rest of North America Artificial Intelligence (AI) in Medical Diagnostics Market by End User
7.4.3 Rest of North America Artificial Intelligence (AI) in Medical Diagnostics Market by Component
Chapter 8. Company Profiles
8.1 Microsoft Corporation
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Product Launches and Product Expansions:
8.1.5.3 Acquisition and Mergers:
8.1.6 SWOT Analysis
8.2 NVIDIA Corporation
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.2.6 SWOT Analysis
8.3 IBM Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional & Segmental Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.3.6 SWOT Analysis
8.4 Intel Corporation
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Product Launches and Product Expansions:
8.4.6 SWOT Analysis
8.5 Google LLC
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.5.6 SWOT Analysis
8.6 Siemens Healthineers AG (Siemens AG)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Product Launches and Product Expansions:
8.6.5.3 Acquisition and Mergers:
8.6.5.4 Approvals and Trials:
8.6.6 SWOT Analysis
8.7 General Electric (GE) Co. (GE Healthcare)
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Product Launches and Product Expansions:
8.7.6 SWOT Analysis
8.8 Xilinx, Inc. (Advanced Micro Devices, Inc.)
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.8.5.2 Acquisition and Mergers:
8.9 Digital Diagnostics, Inc.
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Partnerships, Collaborations, and Agreements:
8.9.2.2 Acquisition and Mergers:
8.10. InformAI, LLC
8.10.1 Company Overview
Unique Offerings 
